245 related articles for article (PubMed ID: 21218818)
1. Synthesis of cationic antimicrobial β(2,2)-amino acid derivatives with potential for oral administration.
Hansen T; Ausbacher D; Flaten GE; Havelkova M; Strøm MB
J Med Chem; 2011 Feb; 54(3):858-68. PubMed ID: 21218818
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent antimicrobial peptide analogs of Ixosin-B.
Lung FD; Wang KS; Liao ZJ; Hsu SK; Song FY; Liou CC; Wu YS
Bioorg Med Chem Lett; 2012 Jun; 22(12):4185-8. PubMed ID: 22578463
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of short arginine- and tryptophan-rich peptides.
Strøm MB; Rekdal O; Svendsen JS
J Pept Sci; 2002 Aug; 8(8):431-7. PubMed ID: 12212806
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide.
Wu YS; Liao ZJ; Wang KS; Lung FD
Bioorg Med Chem Lett; 2013 May; 23(10):2929-32. PubMed ID: 23570790
[TBL] [Abstract][Full Text] [Related]
5. Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria.
Taira J; Kida Y; Yamaguchi H; Kuwano K; Higashimoto Y; Kodama H
J Pept Sci; 2010 Nov; 16(11):607-12. PubMed ID: 20648478
[TBL] [Abstract][Full Text] [Related]
6. New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.
Cerovský V; Slaninová J; Fucík V; Hulacová H; Borovicková L; Jezek R; Bednárová L
Peptides; 2008 Jun; 29(6):992-1003. PubMed ID: 18375018
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and potent antimicrobial activity of some novel 4-(5, 6-dichloro-1H-benzimidazol-2-yl)-N-substituted benzamides.
Ozden S; Karataş H; Yildiz S; Göker H
Arch Pharm (Weinheim); 2004 Oct; 337(10):556-62. PubMed ID: 15476288
[TBL] [Abstract][Full Text] [Related]
8. Improving the biological activity of the antimicrobial peptide anoplin by membrane anchoring through a lipophilic amino acid derivative.
Slootweg JC; van Schaik TB; Quarles van Ufford HL; Breukink E; Liskamp RM; Rijkers DT
Bioorg Med Chem Lett; 2013 Jul; 23(13):3749-52. PubMed ID: 23719232
[TBL] [Abstract][Full Text] [Related]
9. QSAR analysis of antimicrobial and haemolytic effects of cyclic cationic antimicrobial peptides derived from protegrin-1.
Frecer V
Bioorg Med Chem; 2006 Sep; 14(17):6065-74. PubMed ID: 16714114
[TBL] [Abstract][Full Text] [Related]
10. New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.
Yoshizawa H; Kubota T; Itani H; Ishitobi H; Miwa H; Nishitani Y
Bioorg Med Chem; 2004 Aug; 12(15):4211-9. PubMed ID: 15246097
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationships in the tryptophan-rich, antimicrobial peptide indolicidin.
Staubitz P; Peschel A; Nieuwenhuizen WF; Otto M; Götz F; Jung G; Jack RW
J Pept Sci; 2001 Oct; 7(10):552-64. PubMed ID: 11695650
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino/methylaminopiperidin-1-yl)fluoroquinolone derivatives.
Zhang Y; Li G; Liu M; You X; Feng L; Lv K; Cao J; Guo H
Bioorg Med Chem Lett; 2011 Feb; 21(3):928-31. PubMed ID: 21232952
[TBL] [Abstract][Full Text] [Related]
13. Unnatural amino acid side chains as S1, S1', and S2' probes yield cationic antimicrobial peptides with stability toward chymotryptic degradation.
Karstad R; Isaksen G; Brandsdal BO; Svendsen JS; Svenson J
J Med Chem; 2010 Aug; 53(15):5558-66. PubMed ID: 20608742
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G
Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911
[TBL] [Abstract][Full Text] [Related]
15. Supramolecular amphipathicity for probing antimicrobial propensity of host defence peptides.
Ravi J; Bella A; Correia AJ; Lamarre B; Ryadnov MG
Phys Chem Chem Phys; 2015 Jun; 17(24):15608-14. PubMed ID: 25966444
[TBL] [Abstract][Full Text] [Related]
16. Synthetic antimicrobial peptidomimetics with therapeutic potential.
Haug BE; Stensen W; Kalaaji M; Rekdal Ø; Svendsen JS
J Med Chem; 2008 Jul; 51(14):4306-14. PubMed ID: 18570363
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of small beta-peptidomimetics based on the pharmacophore model of short cationic antimicrobial peptides.
Hansen T; Alst T; Havelkova M; Strøm MB
J Med Chem; 2010 Jan; 53(2):595-606. PubMed ID: 19994905
[TBL] [Abstract][Full Text] [Related]
18. Amphiphilic cationic β(3R3)-peptides: membrane active peptidomimetics and their potential as antimicrobial agents.
Mosca S; Keller J; Azzouz N; Wagner S; Titz A; Seeberger PH; Brezesinski G; Hartmann L
Biomacromolecules; 2014 May; 15(5):1687-95. PubMed ID: 24694059
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and in vitro photodynamic antimicrobial activity of basic amino acid-porphyrin conjugates.
Meng S; Xu Z; Hong G; Zhao L; Zhao Z; Guo J; Ji H; Liu T
Eur J Med Chem; 2015 Mar; 92():35-48. PubMed ID: 25544685
[TBL] [Abstract][Full Text] [Related]
20. Salt-resistant short antimicrobial peptides.
Mohanram H; Bhattacharjya S
Biopolymers; 2016 May; 106(3):345-56. PubMed ID: 26849911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
